The recent price decline of 20% in OncoSil Medical Limited's ( ASX:OSL ) stock may have disappointed insiders who...
Key Insights OncoSil Medical's Annual General Meeting to take place on 28th of November CEO Nigel Lange's total...
OncoSil Medical ( ASX:OSL ) Full Year 2023 Results Key Financial Results Net loss: AU$11.3m (loss widened by 5.7% from...